|
No.
|
1086
|
964
| |
|
Proportion girls (%)
|
50.2
|
49.3
|
0.68
|
|
Examination for present study (15 months of age) in rainy season (%)
|
89.6
|
49.3
|
< 0.0001
|
|
SP group : placebo group
|
542 : 544
|
485 : 479
|
0.86
|
|
Current P. falciparum infection
| | | |
|
by microscopy (%; n/n)
|
11.0 (119/1084)
|
24.3 (229/944)
|
< 0.0001
|
|
GMPD (parasites/μL, 95%CI)
|
2312 (1599-3344)
|
1455 (1105-1917)
|
0.03
|
|
by PCR (%)
|
23.6 (248/1049)
|
n.a.
|
-
|
|
Current malaria episode (%, n/n)
|
7.4 (80/1084)
|
11.3 (107/944)
|
0.002
|
|
Febrile (%, n/n)
|
12.8 (138/1082)
|
6.1 (59/964)
|
< 0.0001
|
|
History of fever within 48 h (%, n/n)
|
31.7 (344/1086)
|
31.8 (307/964)
|
0.93
|
|
Haemoglobin (g/dL; mean, range)
|
8.91 (4.7-12.7)
|
9.90 (2.0-15.0)
|
< 0.0001
|
|
Proportion anaemic (Hb < 11 g/dL; %, n/n)
|
94.0 (1019/1084)
|
74.4 (715/961)
|
< 0.0001
|
|
Proportion severely anaemic (Hb < 7 g/dL; %, n/n)
|
8.0 (87/1084)
|
4.9 (47/961)
|
0.004
|
|
Proportion with prior episode(s) of malaria (%, n/n)
|
47.4 (515/1086)
|
57.6 (555/964)
|
< 0.0001
|
|
No. of previous malaria episodes (mean, range)
|
0.67 (0-5)
|
1.23 (0-7)
|
< 0.0001
|
